DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 158 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $25,000 | +13.6% | 2,000 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $22,000 | -21.4% | 2,000 | 0.0% | 0.00% | -20.0% |
Q4 2021 | $28,000 | -26.3% | 2,000 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $38,000 | +90.0% | 2,000 | -3.4% | 0.01% | +75.0% |
Q2 2021 | $20,000 | 0.0% | 2,070 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $20,000 | +122.2% | 2,070 | 0.0% | 0.01% | +150.0% |
Q4 2020 | $9,000 | 0.0% | 2,070 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $9,000 | -50.0% | 2,070 | 0.0% | 0.00% | -57.1% |
Q2 2020 | $18,000 | +63.6% | 2,070 | -32.6% | 0.01% | +40.0% |
Q1 2020 | $11,000 | -81.0% | 3,070 | -69.5% | 0.01% | -77.3% |
Q4 2019 | $58,000 | +28.9% | 10,070 | -19.9% | 0.02% | +10.0% |
Q3 2019 | $45,000 | 0.0% | 12,570 | +8.6% | 0.02% | +5.3% |
Q2 2019 | $45,000 | -66.4% | 11,570 | -36.7% | 0.02% | -72.5% |
Q1 2019 | $134,000 | -35.0% | 18,270 | -18.9% | 0.07% | -49.3% |
Q4 2018 | $206,000 | -43.1% | 22,520 | -22.8% | 0.14% | -37.0% |
Q3 2018 | $362,000 | +13.5% | 29,170 | +39.2% | 0.22% | -36.7% |
Q2 2018 | $319,000 | -9.6% | 20,950 | +11.4% | 0.34% | +30.7% |
Q1 2018 | $353,000 | +7.0% | 18,800 | +1.1% | 0.26% | +5.7% |
Q4 2017 | $330,000 | -21.2% | 18,600 | +3.3% | 0.25% | -34.0% |
Q3 2017 | $419,000 | +288.0% | 18,000 | +50.0% | 0.37% | +231.0% |
Q2 2017 | $108,000 | +103.8% | 12,000 | +16.5% | 0.11% | +101.8% |
Q1 2017 | $53,000 | +32.5% | 10,300 | +8.4% | 0.06% | +1.8% |
Q4 2016 | $40,000 | – | 9,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |